Key result
Genetic deletion of IGFBP-3 in mice preserved insulin sensitivity despite evidence of increased basal glucose turnover and hepatic steatosis.
Why the study?
Does genetic deletion of IGFBP-3 modulate metabolism in mice on a high-fat diet?
Does genetic deletion of IGFBP-3 modulate metabolism in mice on a high-fat diet?
Genetic deletion of IGFBP-3 in mice on a high-fat diet modulates hepatic carbohydrate and lipid metabolism, preserving insulin sensitivity despite increased basal glucose turnover and hepatic steatosis.
This is the authors' abstract. We don't add key points for this paper.
IGF-binding protein (IGFBP)-3 is a metabolic regulator that has been shown to inhibit insulin-stimulated glucose uptake in murine models. This finding contrasts with epidemiological evidence of decreased serum IGFBP-3 in patients with type 2 diabetes. The purpose of this study was to clarify the role of IGFBP-3 in metabolism. Four-week-old male IGFBP-3(-/-) and control mice were subjected to a high-fat diet (HFD) for 12 wk. IGFBP-3(-/-) mice were heavier before the initiation of HFD and at the end of the study period. Resting metabolic rate was significantly decreased in knockout mice; however, respiratory exchange ratio was not significantly different. Fasting blood glucose and insulin levels were significantly elevated in IGFBP-3(-/-) mice. However, IGFBP-3(-/-) mice had relatively normal glucose tolerance because the relative glucose excursion over time was not different between the groups. During hyperinsulinemic clamps, IGFBP-3(-/-) mice had increased basal hepatic glucose production, but after insulin stimulation, no differences in hepatic glucose production were observed. A second cohort of older IGFBP-3(-/-) mice on HFD displayed unexpected evidence of hepatic steatosis. In summary, glucose tolerance and clamp testing indicate that IGFBP-3(-/-) mice preserve insulin sensitivity despite evidence of increased basal glucose turnover and hepatic steatosis. We provide evidence that genetic deletion of IGFBP-3 modulates hepatic carbohydrate and lipid metabolism.
Answers are grounded in this paper and cite their sources.
Does not inform clinical decisions; leaves open IGFBP-3 modulation for insulin resistance.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2010) studied Metabolic regulation. IGFBP-3 genetic deletion (IGFBP-3(-/-)) vs. Control mice was evaluated on Glucose tolerance and insulin sensitivity. Genetic deletion of IGFBP-3 in mice preserved insulin sensitivity despite evidence of increased basal glucose turnover and hepatic steatosis.
Synapse has enriched 10 related papers. Consider them for comparative context: